September 15, 2023, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, concluded the 22nd edition of its annual International Vaccinology Course (IVC) today. A […]

  September 14, 2023, HONG KONG SAR and SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Grid Biosciences (Grid), a biotech company developing […]

September 4, 2023, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), EuBiologics, and DEK Vaccines Limited (DEK) signed a memorandum of understanding (MOU) today at Ghana’s National Vaccine Institute establishing a new partnership to support the fill and finish of the EuBiologics oral […]

September 1, 2023; Oslo, Norway, Seoul, Republic of Korea – The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a renewed collaboration to accelerate the development of vaccines against emerging infectious diseases. The signing ceremony took place between Dr Jerome […]

August 21, 2023 – ANTANANARIVO, Madagascar – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and the Madagascar Institute for Vaccine Research (MIVR) at the University of Antanararivo held […]

July 4, 2023 – LABASA, Fiji – Today, the Ministry of Health and Medical Services (MHMS) of Fiji launched a mass vaccination campaign against typhoid in the Northern Division, aiming to immunize the entire population between 9 months and 65 years of age. The public […]

Based on strong results from a phase 3 trial, SKYCovione™ becomes the 12th  COVID-19 vaccine recognized by WHO IVI supported the global clinical trial, sample analysis, and the regulatory process for the vaccine’s licensure in Korea, UK, and WHO EUL June 23, 2023, SEOUL, Republic […]

  June 21, 2023, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) and Seoul National University signed an agreement to expand collaboration in research.   IVI is the only international organization dedicated to the development and delivery of new vaccines to protect people […]

Report contains key findings for stakeholders engaging in AMR surveillance, research, policy, regulatory decision-making, and other infectious disease prevention and control programs in Bangladesh and wider Asia, supported by the Fleming Fund.     June 20, 2023, SEOUL, Republic of Korea – CAPTURA is a […]

2-week training focuses on technology transfer, talent development, facility management, and aseptic processing Part of the Korean MOHW’s Global Training Hub for Biomanufacturing, the program aims to strengthen local bio production capabilities in LMICs to address vaccine inequity and strengthen pandemic preparedness     June […]

June 2, 2023, DAKAR, Senegal and SEOUL, Republic of Korea – The International Vaccine Institute (IVI) and Institut Pasteur de Dakar (IPD) have signed a Memorandum of Understanding to partner across three areas: 1) to establish IPD as a regional Center of Training Excellence for […]

UK’s MHRA authorizes marketing of SK bioscience’s SKYCovion™ IVI supporting global clinical trial, sample analysis, regulatory process for MA in UK and WHO’s Emergency Use Listing to enhance equitable global access to vaccines June 1, 2023, SEOUL, Republic of Korea  – The UK’s Medicines and […]

IVI and the Government of the Republic of Korea hosted an event on the sidelines of the World Health Assembly with co-sponsoring countries Brazil, Ghana, Kenya, Rwanda, Sweden, and Thailand May 24, 2023, GENEVA, Switzerland  – The International Vaccine Institute (IVI), an international organization with […]

April 28, 2023, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, began clinical development of DuoChol, a new low-cost oral cholera vaccine (OCV) in […]

Awardees give lectures to highlight their work and achievements, share knowledge at the Award Forum     April 26, 2023 – SEOUL, Korea – The International Vaccine Institute (IVI) gave the 2023 IVI-SK bioscience Park MahnHoon Award to Drs. Rino Rappuoli and Mariagrazia Pizza as […]

Seegene to handle logistics support to test 50,000 girls and women ages 9-50 in Asia and Africa from August Seegene’s Allplex™ HPV28 Detection tests to be used to improve access to HPV screening Project funded by the Bill & Melinda Gates Foundation, conducted jointly by […]

March 27, 2023 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, hosted a ceremony at its headquarters in Seoul today in recognition of […]

  March 14, 2023 – SEOUL, Republic of Korea – The Philippine Ambassador to the Republic of Korea, H.E. Ma. Theresa Dizon-de Vega, announced that the Government of the Republic of the Philippines has made a voluntary contribution to the International Vaccine Institute, an international […]

Visits IVI to attend ‘Vaccine Diplomacy Day’ event at the invitation of IVI and Korea Support Committee First Lady Kim: “I am honored to assume the Honorary Presidency. In this capacity, I will do our best to support vaccine development and delivery” First Lady Kim […]

Andrew Pollard / Sarah Gilbert recognized for leading development of Oxford/AZ COVID-19 vaccine Rino Rappuoli / Mariagrazia Pizza honored for discovery of ‘reverse vaccinology’ and development of Meningococcus B vaccine Award Ceremony to take place at IVI on April 25 March 9, 2023, SEOUL, Republic […]

March 8, 2023, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, announced the start of a multi-country study to better understand the burden of […]

January 25, 2023, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, announced today the launch of an IVI Country Office in Austria. This new […]

January 11, 2023, SEOUL, Republic of Korea — Gachon University, the Korea mRNA Vaccine Initiative (KmVAC), and the International Vaccine Institute (IVI) exchanged a memorandum of understanding (MOU) on January 10 to expedite collaboration.   The signing ceremony, held at Gachon University in Seongnam, Gyeonggi […]

January 9, 2023, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), a Seoul, Korea-based international organization devoted to vaccines for global health, and Batavia Biosciences (Batavia), a Dutch CDMO based in Leiden, signed a memorandum of understanding on January 9 to promote cooperation for […]

Provides training for about 40 Afrigen personnel on overall biopharmaceutical production as part of GTH-B program     December 13, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) conducted on-site training and consultation for Afrigen Biologics & Vaccines (Afrigen) in South Africa to help […]

SEOUL, Republic of Korea, December 8, 2022 — The International Vaccine Institute (IVI) received the Trade, Industry and Energy Minister’s Prize in recognition of its efforts to strengthen biosecurity management. Dr. Manki Song, Deputy Director General of Science, received the prize during the ‘K-Bio Leaders’ […]

The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo Results indicate that vaccination with SCB-2019 can […]

Agreement to strategic partnership and collaboration for clinical development of pan-coronavirus mRNA vaccines; promotion of Global Training Hub for Biomanufacturing (GTH-B) for LMICs November 24, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) and ST Pharm announced November 24 that they exchanged […]

November 22, 2022, SEOUL, Republic of Korea – South African based Bio-pharmaceutical company, Biovac, has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV). […]

November 22, 2022, SEOUL, Republic of Korea – The Global Vaccine Leading Technology Center (GVL) in the Republic of Korea and the International Vaccine Institute (IVI) signed a memorandum of understanding (MOU) on November 21 to cooperate in vaccine development for global health. The MOU […]

SK bioscience, IVI convene consultative meeting to discuss cooperation for next pandemic Company announces KRW3 billion donation to IVI to support advancement of global vaccine R&D November 17, 2022, SEOUL, Republic of Korea – SK bioscience, a leading vaccine manufacturer based in the Republic of […]

November 10, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) announced on November 10 it signed a memorandum of understanding (MOU) with Lemonex, a company specializing in RNA gene therapy development, and agreed to seek cooperation in research and development. IVI and Lemonex […]

Course to educate 230 trainees from 33 LMICs and 42 Koreans on GxP to bridge basic knowledge and hands-on training to produce skilled personnel in biomanufacturing   October 31, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) kicked off the ‘Introductory Course […]

H.E. Anutin Charnvirakul, Thailand’s Deputy Prime Minister and Minister of Public Health, made an official visit to IVI: “I strongly believe that a robust collaboration between Thailand and IVI will bring us many opportunities for vaccine research and development, and enable stronger immunization support globally." […]

October 21, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, held its annual State Forum in Seoul yesterday, bringing together representatives from IVI’s […]

October 20, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, launched its Global Advisory Group of Experts today during its inaugural meeting held […]

October 4, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) has signed a three-year Memorandum of Understanding (MOU) with Hilleman Laboratories to establish a collaborative relationship in the pursuit of joint research and development of vaccines to broaden the availability of safe, […]

October 3, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and the London School of Hygiene & Tropical Medicine (LSHTM) signed a Memorandum […]

September 27, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, kicked off its annual International Vaccinology Course on Monday. This year’s course will […]

September 1, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, opened the IVI Europe Regional Office (IERO) in Stockholm today. IERO, housed temporarily […]

Danish Government to contribute 4 million Danish kroner to IVI in 2022 IVI and the Embassy of Denmark in Korea co-organized a seminar on vaccine development and AMR August 30, 2022, SEOUL, Republic of Korea – The Danish Minister for Health, H.E. Magnus Heunicke, visited […]

Africa CDC’s PAVM provided travel scholarships to 50 trainees from 14 African countries IVI to conduct the ‘2022 Introductory Course for Standard Practice (GxP Course)’ in October to educate 300 trainees and bridge basic knowledge with hands-on training July 29, 2022, SEOUL, Republic of Korea […]

July 20, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, signed […]

Funded by Korean MOHW, new course is conducted as part of 'Global Bio-Intensive Training Courses’ to promote Korea as Global Training Hub for Biomanufacturing 2-week program expected to help increase LMICs’ capability in local bio production to address vaccine inequity, enhance global pandemic preparedness July […]

June 20, 2022 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced that Spain joined IVI, an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.   His Excellency Juan Ignacio Morro, Ambassador of […]

New evidence supports the use of alternative dosing formulations, expanding TCV delivery options in public health programs     June 14, 2022 – SEOUL, Republic of Korea – A new study jointly conducted by the International Vaccine Institute (IVI) and collaborators shows multidose and single-dose […]

June 7, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) and Egyptian Agency of Partnership for Development (EAPD) held the 2022 EAPD-IVI Online Vaccine Symposium today to support the advancement of vaccine manufacturing capacity in Africa.   The symposium highlighted challenges and […]

June 3, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) is pleased to announce that the Republic of Rwanda joined IVI, an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health. Her Excellency […]

  May 23, 2022– SEOUL, Republic of Korea and ADDIS ABABA, Ethiopia – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines, and Armauer Hansen Research Institute (AHRI), established by the Government of […]

May 18, 2022, SEOUL, Republic of Korea – Today, the International Vaccine Institute (IVI) and the Ministry of Health, and Family Welfare (MOHFW) of Bangladesh shared key findings from the Capturing data on Antimicrobial resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) […]

2 ECCP projects to contribute to the government’s efforts towards control and prevention of cholera and diarrheal diseases May 13, 2022, SEOUL, Korea — The International Vaccine Institute (IVI), in collaboration with LG Electronics, the Ethiopian government led by Armaur Hansen Research Institute (AHRI), and the […]

Agree to expand collaboration in vaccine development & delivery, training Exchange additional letter of intent on cooperation in epidemiology training May 13, 2022, SEOUL, Korea — The International Vaccine Institute (IVI) and the Disease Control and Prevention Agency (KDCA), Republic of Korea, exchanged a memorandum of […]

‘SKYTyphoid’ TCV developed jointly by IVI and SK bioscience, licensed for export by Korean Ministry of Food and Drug Safety Vaccine demonstrates non-inferiority to comparator vaccine PQed by WHO; single dose provides long-term protection Vaccine will be available to infants under age 2; SK bioscience […]

Recombinant protein-based ‘SKYCovione™’ adjuvanted with GSK’s pandemic adjuvant demonstrates superior neutralizing titers compared to a control vaccine and safety SK bioscience submits a biologics license application to KMFDS, and will submit license applications to international regulatory agencies Company set to supply 10 million doses of […]

OCV vaccination campaign targets Rupani Rural Municipality to control ongoing outbreak of cholera and diarrheal diseases Project to assess feasibility of self-administration strategy for the 2nd dose of OCV May 4, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), in collaboration with SmileGate […]

8th UN Secretary-General Ban Ki-moon congratulates awardees, lauds their contributions to global health and vaccine innovation April 25, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) hosted the 2022 Award Ceremony of the IVI-SK bioscience Park MahnHoon Award today, honoring Dr. […]

April 20, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with the mission to discover, develop and deliver safe, effective and affordable vaccines for global health, announced today that Dr. Ximena Garzón Villalba, Minister of Public Health of […]

April 1, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) and the Ministry of Health and Welfare (MOHW), Republic of Korea, have agreed to strengthen cooperation to promote the development and delivery of vaccines and bio manufacturing workforce training for low- and […]

Godal recognized for contributions to delivery of crucial vaccines for millions of children in low-income countries Weissman and Karikó honored for the development of pivotal mRNA technology for vaccines against COVID-19 Award ceremony to take place at IVI on April 25 March 24, 2022 – […]

  March 17, 2022 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the United Arab Emirates (UAE) joined IVI, becoming the international organization’s 37th member state. His Excellency Abdulla Saif Al Nuaimi, Ambassador of the UAE to the Republic of […]

Institute to run training program on vaccines and biologics development and manufacturing and GxP for 450 trainees from LMICs and Korea   February 16, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) has been designated by the Ministry of Health and Welfare […]

January 27, 2022 – SEOUL, Republic of Korea – A new study shows that late booster dosing with Vi polysaccharide conjugated with diphtheria toxoid (Vi-DT), one of the typhoid conjugate vaccines (TCVs), at 27.5 months post-first dose is safe and elicits robust immune responses in […]

  IVI and the National Vaccine Institute (NVI) of Thailand signed a Definitive Agreement to strengthen their collaborative partnership   January 20, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) and the National Vaccine Institute (NVI) of Thailand signed a Definitive […]

Recruitment of global Phase III clinical trial of ‘GBP510’ completed, with vaccine expected to be authorized in the first half of 2022 A booster dose study is concurrently being planned to bring additional vaccine to the global COVID-19 vaccine market   January 19, 2022 SEOUL, […]

Study will assess the safety and immunogenicity of a heterologous regimen of two approved COVID-19 vaccines in adults Aims to mitigate vaccine shortages and support flexible immunization programs   December 20, 2021, SEOUL, Republic of Korea; MAPUTO, Mozambique; OSLO, Norway – The International Vaccine Institute […]

IVI and the Government Offices of Sweden signed a Memorandum of Understanding today to establish the office in Stockholm, creating a European hub for global health research and innovation   December 17, 2021, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international […]

    The webinar “Curbing the Invisible Pandemic: Effective Solutions to Collectively Combat Antimicrobial Resistance” was held on December 7, 2021   December 7, 2021 — The International Vaccine Institute (IVI), Asian Development Bank Southeast Asia Development Solutions (ADB SEADS), Institut Pasteur Korea (IPK), the […]

Cited for contributions to development of vaccines, joining 8 foreign residents to receive Honorary Citizenship in 2021 Second Honorary Seoul Citizen from IVI   SEOUL, Korea — Dr. Sushant Sahastrabuddhe, Associate Director General at the International Vaccine Institute (IVI), has been awarded “Honorary Citizenship of […]

IVI, SK sign an agreement to launch the ‘Park MahnHoon Award’ to honor individuals and organizations that made contributions to the vaccine industry Award Ceremony will be held annually in April; IVI and SK ‘committed to establish the new award as a prestigious award for […]

To promote the safety and attractiveness of traveling Korea amidst gradual restart of global tourism     The Ministry of Culture, Sports and Tourism (Minister Hwang Hee) and the Korea Tourism Organization (KTO, President Ahn Young-bae) appointed Dr. Jerome H. Kim, Director General of the […]

  The International Vaccine Institute (IVI) has been honored with the Presidential Citation of the Republic of Korea’s Development Cooperation Award, in recognition of IVI’s contributions to global health and Korea’s official development assistance.   IVI has been cited as being an “International organization focused […]

  Dr. Jerome Kim, Director General and Dr. Song Manki, Deputy Director General of Science of the International Vaccine Institute (IVI) joined distinguished global leaders and experts as moderator and speaker at the first World Emerging Security Forum, which took place in Seoul on November […]

October 25, 2021 – SEOUL, Republic of Korea, PARIS, France, BRUSSELS, Belgium, BERLIN, Germany – The International Vaccine Institute (IVI) and the Joint European Disruptive Initiative (JEDI) signed a Memorandum of Understanding to establish a collaborative relationship. Both organizations are dedicated to advancing innovations in […]

Until Everyone Is Safe: Global Vaccine Needs and IVI’s Capabilities was livestreamed on October 7, 2021 at 16:00 Korea Standard Time, and a recording of the event is available here.         October 7, 2021, SEOUL, Republic of Korea — The International Vaccine […]

Sept. 28, 2021 – SEOUL, South Korea, and HOUSTON, Texas, USA – The International Vaccine Institute (IVI), the Texas Children’s Hospital Center for Vaccine Development, and Baylor College of Medicine’s National School of Tropical Medicine signed a Memorandum of Understanding to promote and further academic […]

International Vaccine Institute (IVI) will lead the clinical trial in Nepal to assess the safety, efficacy and immunogenicity of an adjuvanted recombinant-protein COVID-19 vaccine candidate Phase 3 international clinical trial includes volunteers from several countries, including sites in the US, Asia, Africa and Latin America […]

September 10, 2021, SEOUL, Korea — The International Vaccine Institute’s (IVI) 20th International Vaccinology Course (IVC) concluded today, bringing together 7,350 registered trainees and 27 faculty members for 5 days of online lectures on a range of topics related to the science of vaccines with […]

Learn more and register for the free 5-day virtual course (6-10 September 2021) on a range of topics related to vaccinology here September 6, 2021 SEOUL, Korea — The International Vaccine Institute’s (IVI) 20th annual International Vaccinology Course (IVC), a 5-day free, online course begins […]

The President of Colombia delivers letter of intent for Colombia to join IVI IVI and Colombia’s Ministry of Health and Social Protection sign memorandum of understanding August 25, 2021 – SEOUL, Republic of Korea – The President of the Republic of Colombia, His Excellency Iván […]

IVI is leading the Global Chikungunya vaccine Clinical Development Program (GCCDP) consortium in partnership with Bharat Biotech International Ltd. and with support from the Coalition for Epidemic Preparedness Innovations (CEPI) and Ind-CEPI.   August 24, 2021 – SEOUL, Republic of Korea – The International Vaccine […]

August 18, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) named Sae Eun Park, an award-winning ballet dancer from Korea, an IVI Goodwill Ambassador during a virtual ceremony in Seoul today.   Ms. Park was named danseuse étoile, the highest-level dancer, […]

IVI to conduct Phase 3 clinical trials of SK bioscience’s recombinant protein vaccine candidate (GBP510) in Europe and Southeast Asia   Additionally, IVI forms partnership with SK and KNIH to jointly conduct antibody testing for the global trials to accelerate development of “Wave 2” vaccines […]

July 26, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) announced today the start of a cluster-randomized, controlled Phase IV trial to assess the effectiveness of Typbar® typhoid conjugate vaccine (TCV) in preventing typhoid infection in children in Asante Akim, Ghana […]

July 20, 2021; Oslo, Norway and Seoul, Republic of Korea: The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa. CEPI will provide funding […]

  July 15, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) hosted a ceremony at headquarters today honoring the People’s Republic of Bangladesh’s ratification of the IVI Establishment Agreement. Over 20 years of vaccine research and capacity-building initiatives with partners in Bangladesh […]

July 5, 2021 – SEOUL, Republic of Korea and KUMASI, Ghana – The International Vaccine Institute (IVI) and the Kwame Nkrumah University of Science and Technology (KNUST) opened the KNUST-IVI Collaborating Center today with a ceremony at KNUST/Agogo Presbyterian Hospital.   The KNUST-IVI Collaborating Center […]

The ROK-Australia-ASEAN Vaccine Forum took place in hybrid live/virtual format with transmission from Seoul on June 29, 2021   June 29, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) organized, and the Republic of Korea’s Ministry of Foreign Affairs (MOFA) and […]

May 31, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded a grant to IVI to develop an adaptive trial design protocol for a Phase 1b/2a clinical trial of a schistosomiasis vaccine.   […]

The agreement is an effort to further scientific research in infectious diseases and make knowledge more accessible through advocacy and joint publications.   May 19, 2021 – SEOUL, South Korea, RIYADH, Saudi Arabia – The International Vaccine Institute (IVI) and the Future Investment Initiative Institute […]

April 1, 2021, GYEONGDO-DO and SEOUL, Korea – The International Vaccine Institute (IVI) and the Institut Pasteur Korea (IPK) signed a memorandum of understanding (MOU) for mutual collaboration in the research and development of therapeutics and vaccines for infectious diseases.   The MOU signing ceremony, […]

  March 12, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) and the Nepal Health Research Council (NHRC) signed a Memorandum of Understanding (MoU) today during a virtual ceremony, laying the foundation for the two organizations to build research and development capacity […]

March 9, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) welcomes the Cabinet of Bangladesh’s decision to ratify the IVI Establishment Agreement on February 22, 2021, completing the full accession process to IVI and becoming its 19th State Party.     Bangladesh is a founding signatory to IVI’s […]

February 22, 2021, SEOUL, Korea – The International Vaccine Institute (IVI) announced today that its Board of Trustees (BOT) re-elected Mr. George Bickerstaff as Chairperson of the BOT. His second three-year term will begin this May.   Mr. Bickerstaff has served on the IVI Board […]

To cooperate in clinical development of COVID-19 vaccine candidate GI-Cell aims to prioritize supplying to Korea and developing countries by developing a vaccine that accommodates mass supply, viral mutation response, safety, convenience of patients January 26, 2021, SEOUL, Korea – GI-Cell, an affiliate of GI-Innovation, […]

IVI to analyze samples from Phase 1/2a trials of Cellid’s COVID-19 vaccine to evaluate immunogenicity   January 5, 2021, SEOUL, Korea –  Cellid and the International Vaccine Institute (IVI) have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19”.   […]

Primary analysis also confirms safety of Vi-DT   December 17, 2020 – SEOUL, South Korea – Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal. The primary […]

December 3, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) and EuBiologics exchanged an MOU to cooperate in clinical development of the COVID-19 vaccine the company is currently developing. The signing ceremony at IVI headquarters on December 2 was attended by Dr. Jerome […]

Free webinar, Evidence to Action: Advancing the Antimicrobial Resistance Agenda during a Pandemic, will be held on Thursday, December 3, 2020 at 9:00 Central European Time (17:00 Korean Standard Time). Registration available at ivi.int/evidence-to-action/    December 1, 2020, SEOUL, Korea — The International Vaccine Institute […]

December 1, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) visited the Seoul Gwanak Police Station today to recognize the Foreign Affairs section for their ongoing support for IVI’s activities and to deliver protective face masks and medical supplies for staff and volunteers. […]

GDEF’s US$8.05 million grant to support ECHO projects to prevent and control cholera and contribute to ‘Ending Cholera—A Global Roadmap to 2030’   The International Vaccine Institute (IVI) and the Republic of Korea’s Global Disease Eradication Fund (GDEF) have agreed to conduct joint projects to […]

November 24, 2020, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) and the Ministry of Foreign Affairs and Human Mobility of Ecuador exchanged a memorandum of understanding (MOU) today at IVI headquarters in Seoul, Republic of Korea to explore areas of collaboration in […]

Project to provide vaccination for 40,000 residents in areas at risk of cholera and establish disease monitoring system with the Ethiopian Ministry of Health through the Armauer Hansen Research Institute (AHRI) To contribute to health authorities in policymaking for disease prevention by investigating waterborne diseases […]

Aim to accelerate R&D and globalization of Korean vaccines to increase contributions to global health     The International Vaccine Institute (IVI) and the Vaccine Innovative Technology ALliance Korea (VITAL-Korea) agreed to join forces to promote vaccine research and development for global health.   IVI […]

October 28, 2020, SEOUL, Korea —  The International Vaccine Institute (IVI) received an award by the Minister of Health and Welfare of the Republic of Korea for achievements in biosafety management.   IVI was honored with the Minister of Health and Welfare Award for achievements in […]

The International Vaccine Institute (IVI) is partnering with the World Sanity Foundation (WSF) in a campaign to encourage the use of face masks in an effort to reduce the spread of COVID-19 cases until a safe and effective vaccine becomes widely available.   The first […]

October 13, 2020, SEOUL, Korea — The International Vaccine Institute (IVI) hosted a virtual State Forum today to advocate for multilateral cooperation through vaccine diplomacy. During a coronavirus pandemic with the continuous threat of more neglected infectious diseases spreading around the world, the forum convened […]

September 17, 2020 – SEOUL, South Korea – A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of age, a group with high […]

September 9, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded close to 1.5 million USD to IVI to support clinical trial site preparedness in four African and Asian countries to potentially support future COVID-19 Phase III efficacy vaccine trials.     Following successful completion of early-stage clinical trials of COVID-19 vaccine candidates, it will be […]

  August 10, 2020 – SEOUL, South Korea – The flag of Finland was raised at the International Vaccine Institute (IVI) Headquarters today during a ceremony welcoming the country’s accession to IVI. Finland joined the Seoul-based international organization dedicated to vaccines for global health in […]

IVI hosted the “Shared Future, Global Solidarity: Vaccines Save Lives” event at its headquarters on July 8, 2020, attended by the First Lady, Minister of Health, Vice Minister of Foreign Affairs, Director of National Institute of Health of Korea, and foreign ambassadors to South Korea […]

LINE FRIENDS’ BT21 characters featured in IVI sticker set to raise funds for child immunization initiatives and COVID-19 vaccine development   SEONGNAM, South Korea – June 30, 2020 – LINE Corporation today released a set of animated stickers together with the International Vaccine Institute (IVI) […]

  June 16, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) welcomed His Excellency Einar H. Jensen, Ambassador of Denmark to South Korea, to IVI’s headquarters today to discuss developments in COVID-19 research as well as the institute’s ongoing studies on antimicrobial resistance […]

First COVID-19 vaccine clinical study approved in South Korea funded by CEPI through INOVIO, and supported by KCDC/KNIH 2-stage trial to test INOVIO’s COVID-19 vaccine (INO-4800) using well-established DNA platform technology in adults     June 4, 2020, SEOUL, Korea and PLYMOUTH MEETING, PA, USA […]

  June 3 2020, Oslo, Norway; Seoul, South Korea; Telangana, India—CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, has announced a new partnering agreement with a consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to advance the development of […]

SEOUL, KOREA — March 10, 2020 — Veeva Systems (NYSE:VEEV) today announced that the International Vaccine Institute (IVI), a not-for-profit International Organization established in 1997 as an initiative by the United Nations Development Programme (UNDP), has implemented Veeva Vault QualityDocs to improve control and real […]

May 22, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) invited French Ambassador to Korea, Philippe Lefort, to IVI’s headquarters in Seoul, Korea today to share ongoing research and development on COVID-19.   His Excellency Philippe Lefort, French Ambassador to Korea (left), and […]

IVI will leverage its network of infectious disease surveillance sites to conduct epidemiological studies of COVID-19 in Madagascar and Burkina Faso Sida’s contribution will significantly build in-country capacity to proactively respond to the pandemic     May 21, 2020 – SEOUL, South Korea – The […]

INO-4700 (GLS-5300) DNA vaccine demonstrates 100% binding and 92% neutralizing antibody responses against MERS-CoV INO-4800 DNA vaccine for COVID-19 currently in Phase 1 trial utilizes identical strategy targeting Spike protein and CELLECTRA intradermal delivery   PLYMOUTH MEETING, Pa. and SEOUL, KOREA – April 28, 2020 […]

LINE to offer an Official Account to IVI to promote the importance of vaccines and vaccination, as well as feature educational contents starring IVI Goodwill Ambassador Henry Lau LINE FRIENDS’ BT21 character IVI sticker set to be launched in the first half of the year […]

  The Coalition for Epidemic Preparedness Innovations (CEPI) grants funding $6.9 million to INOVIO and IVI to conduct clinical testing in Korea for INOVIO’s COVID-19 vaccine candidate based on their well-established DNA platform technology Korea National Institute of Health (KNIH) to support IVI’s testing efforts […]

The Asia Pacific region is vulnerable to the emergence and spread of AMR but there is little high-quality data available on the extent of its impact Quality-assured data is essential for building tailored strategies for preventing the spread of drug-resistant infections IVI is part of […]

    January 13, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI), a Seoul, Korea-based international organization, announced today that the Swedish International Development Cooperation Agency (Sida) will continue to support IVI’s mission to accelerate vaccine research and development for global health […]

  January 9, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI) received a $1.4 million grant from the Bill & Melinda Gates Foundation to ensure critical standards and reagents are available to low-cost oral cholera vaccine (OCV) manufacturers in the global health […]

December 18, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI), a Seoul, Korea-based international organization dedicated to accelerating vaccines for global health, announced today that Professor Gordon Dougan, Dr. Melanie Saville, and Dr. Jean-Marie Okwo-Bele will join its Board of Trustees (BOT) […]

An award from the Wellcome Trust’s Affordable Innovations for Global Health Flagship will support IVI’s development and selection of potential vaccine candidates There is currently no vaccine available to protect against invasive non-typhoidal salmonella (iNTS)   November 13, 2019 – SEOUL, South Korea – The […]

Institute expected to increase contributions to vaccine development activities worldwide   November 1, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI), an international organization for vaccine development and delivery headquartered in Seoul, has been granted Good Clinical Laboratory Practice (GCLP) certification by […]

October 28, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI) has received a $4.5 million grant from the Bill & Melinda Gates Foundation to simplify the current oral cholera vaccine (OCV) and further increase its accessibility. To date, the Gates Foundation has […]

IVI State Forum 2019 was attended by 8th UN Secretary-General Ban Ki-moon, as well as 30 distinguished guests, including 17 ambassadors and top diplomats in Seoul, and senior Korean government officials.   The IVI State Forum 2019 was attended by ambassadors and senior diplomats from […]

September 24, 2019, SEOUL, Korea – The Chief Medical Officer for England, Dame Sally Davies, announced today during the 74th UN General Assembly that a consortium led by the International Vaccine Institute (IVI) has been awarded a £2.7m Fleming Fund Regional Grant to improve data […]

19th IVI International Vaccinology Course brings together 175 trainees and faculty members from 49 countries The annual course has trained over 1,544 healthcare professionals in vaccine development, evaluation, production and policy to help increase developing nations’ capacity in vaccine research and immunization.     September […]

  August 28, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI) has received additional funds of $4.33 million from the Bill & Melinda Gates Foundation to expand Severe Typhoid in Africa (SETA) Program activities in close alignment with the “Effect of a […]

August 16, 2019 – SEOUL, South Korea – Dr. Jerome Kim, Director General of the International Vaccine Institute (IVI), joins the Human Vaccines Project as one of four distinguished global leaders to help push forward its effort to solve one the greatest public health challenges […]

Fund to support IVI’s projects to vaccinate children in developing countries throughout Asia-Pacific and Africa, to develop vaccines against emerging viruses   Prof. Park Sang-chul, President of the Korea Support Committee for IVI, Prof. Sung Young-chul with his donation pledge and IVI Director General Dr. […]

Streptococcus pyogenes bacteria, which causes scarlet fever and other infections   30 May 2019, SEOUL, South Korea – The International Vaccine Institute (IVI) and Australia’s Murdoch Children’s Research Institute (MCRI) will coordinate a global push to free the world of Group A Streptococcus (Strep A), […]

SEOUL, South Korea — An international consortium, led by the International Vaccine Institute (IVI), has received funding from the UK’s Fleming Fund Regional Grants to conduct the Capturing Data on Antimicrobial Resistance (AMR) Patterns and Trends in Use in Regions of Asia (CAPTURA) project. The […]

– Grant from the Bill & Melinda Gates Foundation will support additional supply of novel TCV at affordable cost for public sector markets   SEOUL, Korea –The International Vaccine Institute (IVI) announces receipt of a $15.7 million-dollar grant from the Bill & Melinda Gates Foundation […]

– Event organized by IVI to discuss ways of cooperation to help increase Korea’s vaccine self-sufficiency, and accelerate globalization of the Korean vaccine industry Key participants pose for a commemorative photo at the ‘IVI Forum for Enhancement of Cooperation’ at the National Assembly of the […]

Recently, the sensitivity of fecal microbiological cultures for detecting cholera has come under question. Researchers reporting in PLOS Neglected Tropical Diseases investigated this claim using a ‘vaccine probe’ analysis of a completed cholera vaccine cluster randomized trial to support the sensitivity of conventional microbiological culture […]

KPA, as group of experts in pediatric infectious diseases, to collaborate in academic research and projects on infectious disease prevention To support vaccination of children in developing countries through the ‘One for Three’ campaign, in partnership with IVI     The International Vaccine Institute (IVI), […]

  SEOUL, Korea — The International Vaccine Institute (IVI) has been awarded a $3,238,974 grant from the Bill & Melinda Gates Foundation to provide technical assistance support for studies to measure the effectiveness of typhoid conjugate vaccine (TCV) in West Africa. This grant comes after […]

– Bilateral ‘Master Implementing Partner Services Agreement’ expected to enable IVI to provide technical capabilities to CEPI   Oslo, Norway; Seoul, Republic of Korea 11 February 2019—The Coalition for Epidemic Preparedness Innovations (CEPI) and the Republic of Korea-based International Vaccine Institute (IVI), an international organisation […]

– Singer-songwriter, Henry to team up with the International Vaccine Institute (IVI), founded by the United Nations Development Programme to develop and deliver new vaccines for global health – IVI Director General Dr. Jerome Kim: “IVI is privileged to have Henry on board, and grateful […]

New study in Nature Communications reveals high burden of multi-drug resistant (MDR) typhoid fever in sub-Saharan Africa associated with two predominant genotypes – IVI epidemiologist Se Eun Park and collaborating scientists report data from Typhoid Fever Surveillance in Africa (TSAP) program and other sources   […]

First cooperative program between International Vaccine Institute and Translational Health Science and Technology Institute expected to help accelerate cooperation between India and IVI IVI and the Translational Health Science and Technology Institute (THSTI) of India held a joint symposium at IVI headquarters on November 22. […]

“The Euvichol Story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships” spearheaded by the International Vaccine Institute (IVI), has been published in Vaccine by Elsevier. The Euvichol Story published on October 9, 2018 in the […]

– Institute jointly conducts phase 1/2a clinical trial of GeneOne Life Science’s GLS-5300 DNA MERS vaccine – IVI in search of additional promising candidate vaccines among developers worldwide, with support from Samsung Life Public Welfare Foundation   The International Vaccine Institute (IVI) said on September […]

Annual Course to update on the recent development in vaccinology, including basics of immunology, epidemiology, vaccine design and development Featured experts include: Stanley Plotkin (University of Pennsylvania), Dr. Barney Graham (US NIH), Dr. Randy Schoepp (USAMRID), Dr. Andy Pollard (University of Oxford), and Dr. Eric […]

– Joint initiative aims to prevent and control cholera, and secure sustainable cholera and diarrheal disease surveillance  – WASH campaign to promote access to clean water and behavioral change for appropriate sanitation and hygiene practice – “KOICA is joining the program to contribute to ‘Ending […]

– Grant from the Bill & Melinda Gates Foundation to allow SK Bioscience Co. Ltd, IVI to accelerate late-stage development of new vaccine necessary to achieve WHO prequalification The International Vaccine Institute (IVI), an international nonprofit organization devoted to providing vaccines critical to global public […]